Patent · US Expired

Low molecular weight peptidomimetic growth hormone secretagogues

US5798337A · kind A · utility

27Cited by
20References
26Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 16, 1994
Grant dateAug 25, 1998
Priority date
Expiry dateNov 16, 2014

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention comprises growth hormone releasing peptides/peptidomimetics (GHRP) capable of causing release of growth hormone from the pituitary. Compositions containing the GHRP's of this invention are used to promote growth in mammals either alone or in combination with other growth promoting compounds, especially IGF-1. In a method of this invention GHRP's in combination with IGF-1 are used to treat Type II diabetes. An exemplary compound of this invention is provided below. ##STR1##

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.